Advanced Clinical Trial Support Hub Launched in South Korea
Leading healthcare solutions company in Asia, Zuellig Pharma, on November 30, 2025, confirmed through an announcement the grand opening of its new state-of-the-art Clinical...
A Possible New US Manufacturing Hub from Novartis
In a latest move, a pharma major has announced its plans to build a new US manufacturing hub based out of North Carolina. The...
Merck Announces Acquisition of Cidara Therapeutics at $9.2 B
Merck announced that it will acquire Cidara Therapeutics, Inc., after both companies confirmed they have signed a definitive agreement. The deal, executed through a...
Novartis Opens Radioligand Therapy Manufacturing Plant in US
Novartis, a leader in innovative medicines, has launched a 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. The site marks an important step...
Lilly to Expand its Manufacturing Facility in Puerto Rico
Eli Lilly and Company has unveiled plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in...
Lilly to Build $3B Manufacturing Facility in Netherlands
Eli Lilly and Company is investing $3 billion to build a new manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park....
Lilly, NVIDIA Partner on AI Supercomputer for Drug Research
Eli Lilly and Company has revealed plans to construct what it calls the most powerful supercomputer ever built and operated by a pharmaceutical company,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...